Results 21 to 30 of about 1,751 (120)
Differential Gene Expression in Post-Finasteride Syndrome Patients
The Journal of Sexual Medicine, 2021 ABSTRACTBackgroundAn organic etiology underpinning post-finasteride syndrome, a constellation of persistent sexual, neuropsychiatric, and somatic symptoms reported by men exposed to 5-alpha-reductase inhibitors (5ARIs), is debated. Persistent changes in neurosteroid levels or androgen receptor expression have been implicated.AimTo determine whether ...
Skyler, Howell +3 more
openaire +2 more sources
Metabolites, 2020 Male pattern baldness (MPB) has been associated with dihydrotestosterone (DHT) expression. Finasteride treats MPB by inhibiting 5-alpha reductase and blocking DHT production.
Yu Ra Lee +9 more
doaj +1 more source
The Effect of Hypnotherapy on the Resilience of Women With Polycystic Ovarian Syndrome: Study Protocol for a Randomized Controlled Trial. [PDF]
Health Sci RepABSTRACT Background and Aims Polycystic ovarian syndrome, with a mean incidence of 5–10, is the most common endocrine disorder affecting women of reproductive age. These patients suffer from a wide range of symptoms that are inversely related to their resilience and quality of life.
Khani S +4 more
europepmc +2 more sources
Post-finasteride syndrome: a surmountable challenge for clinicians [PDF]
Fertility and Sterility, 2020 Post-finasteride syndrome (PFS) is a constellation of serious adverse side effects manifested in clinical symptoms that develop and persist in patients during and/or after discontinuing finasteride treatment in men with pattern hair loss (androgenetic alopecia) or benign prostatic hyperplasia.
openaire +2 more sources
Post-finasteride syndrome – does it really exist?
The Aging Male, 2019 Inhibitors of 5α-steroid reductase are drugs used to treat androgen-dependent conditions including prostate diseases and androgenic alopecia. Finasteride was the first on the market and is currently the most widely used inhibitor. Dutasteride was the second inhibitor to be approved and has a similar safety profile.
Radosław B. Maksym +2 more
openaire +2 more sources
Emotional Consequences of Finasteride: Fool’s Gold
American Journal of Men's Health, 2018 Androgenetic alopecia, the gradual, progressive loss of hair frequently results in psychological despair, in part related to changes in self-image. Current androgenetic alopecia treatments are limited to hair transplantation and medications that inhibit ...
Christine Anne Ganzer PhD +1 more
doaj +1 more source
Persistent Sexual, Emotional, and Cognitive Impairment Post-Finasteride
American Journal of Men's Health, 2015 Finasteride is a synthetic 5-α reductase inhibitor, which prevents the conversion of testosterone to dihydrotestosterone and has been used for more than 20 years in the treatment of male pattern hair loss.
Christine Anne Ganzer PhD +2 more
doaj +1 more source
American Journal of Men's Health, 2018 Our research objective is to understand more, through subjective, self-reports on discussion boards/forums, persons’ experiences associated with the use of drugs that alter androgen metabolism, such as finasteride.
Alicia A. Walf +2 more
doaj +1 more source
Finasteride as a model for personalized medicine
Journal of Mind and Medical Sciences, 2017 The side effects of Finasteride are currently a subject of controversy. Some studies report minor or acceptable adverse effects, which decrease after a variable period of time so that they do not necessitate terminating Finasteride administration ...
Ion G. Motofei +5 more
doaj +1 more source
Post-Finasteride Syndrome (PFS) Update: Point/Counterpoint [PDF]
International Society of Hair Restoration Surgery, 2016 1. Edwin S. Epstein, MD, FISHRS (esehairmd{at}gmail.com) 1. Richmond, Virginia, USA At the ISHRS 2015 Annual Scientific Meeting in Chicago, we heard an update on the constellation of symptoms that has come to be known as Post-Finasteride Syndrome (PFS).
openaire +1 more source